Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib

Published:2021-03-12 Issue:10 Volume:100 Page:e25046
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Lai Lin,Meng Wentao,Wei Jialiang,Zhang Xiaofei,Tan Zhiwei,Lu Yunxin,Hou Encun

Funder

The self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province

The Science Foundation for Distinguished Young Scholars of Guangxi University of Chinese Medicine

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference10 articles.

1. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci Transl Med,2011

2. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers;Yu;Clin Cancer Res,2013

3. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer;Jänne;N Engl J Med,2015

4. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin;Oser;Lancet Oncol,2015

5. Heterogeneity underlies the emergence of EGFRT790 wild-type clones following treatment of T790M-positive cancers with a third-generation EGFR inhibitor;Piotrowska;Cancer Discov,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic option for EGFR-mutant small cell lung cancer transformation: a case report and literature review;Frontiers in Immunology;2024-08-21

2. ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report;Frontiers in Oncology;2024-04-23

3. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol;The Oncologist;2023-12-18

4. Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes;Journal of Thoracic Oncology;2023-11

5. Current knowledge of small cell lung cancer transformation from non-small cell lung cancer;Seminars in Cancer Biology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3